The Office of Dietary Supplements at the National Institutes of Health is helping to finance a three-year multicenter study of St. John's wort as a treatment for clinical depression and a study of plant-based estrogens as a preventive for postmenopausal health problems.
A year ago, the President's Commission on Dietary Supplement Labels recommended that the FDA appoint a committee to evaluate the safety and effectiveness of herbal products.
But some in the dietary supplement industry are at odds with the government's descriptions that some supplements _ particularly those containing ephedrine _ are dangerous.
